Nancy E. Davidson

78.7k total citations · 17 hit papers
398 papers, 41.0k citations indexed

About

Nancy E. Davidson is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Nancy E. Davidson has authored 398 papers receiving a total of 41.0k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Oncology, 149 papers in Cancer Research and 142 papers in Molecular Biology. Recurrent topics in Nancy E. Davidson's work include Breast Cancer Treatment Studies (128 papers), HER2/EGFR in Cancer Research (79 papers) and Estrogen and related hormone effects (71 papers). Nancy E. Davidson is often cited by papers focused on Breast Cancer Treatment Studies (128 papers), HER2/EGFR in Cancer Research (79 papers) and Estrogen and related hormone effects (71 papers). Nancy E. Davidson collaborates with scholars based in United States, Canada and United Kingdom. Nancy E. Davidson's co-authors include Edith A. Perez, James D. Yager, Yvonne Ottaviano, Stephen B. Baylin, Silvana Martino, Julie R. Gralow, Jean‐Pierre J. Issa, Molin Wang, Scott H. Kaufmann and Rena G. Lapidus and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Nancy E. Davidson

392 papers receiving 40.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the p53 gene occur in diverse human tumour types

1989 2.4k citations Nancy E. Davidson et al. profile →
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

2007 2.3k citations Kathy D. Miller, Molin Wang et al. profile →
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

1993 1.7k citations Nancy E. Davidson et al. PubMed profile →
Estrogen Carcinogenesis in Breast Cancer

2006 1.4k citations Nancy E. Davidson et al. profile →
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

1995 1.2k citations Nancy E. Davidson et al. PubMed profile →
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

1994 980 citations Nancy E. Davidson et al. profile →
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

2014 953 citations Sylvia Adams, Robert J. Gray et al. Journal of Clinical Oncology profile →
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

2005 818 citations James N. Ingle, Silvana Martino et al. profile →
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

2008 672 citations Joseph A. Sparano, Molin Wang et al. profile →
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

2014 671 citations Edith A. Perez, Vera J. Suman et al. Journal of Clinical Oncology profile →
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

1995 668 citations Nancy E. Davidson et al. PubMed profile →
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

2010 612 citations Harold J. Burstein, Holly Anderson et al. Journal of Clinical Oncology profile →
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

2014 559 citations Harold J. Burstein, Sarah Temin et al. Journal of Clinical Oncology profile →
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

2011 539 citations Edith A. Perez, Vera J. Suman et al. Journal of Clinical Oncology profile →
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

2018 411 citations Harold J. Burstein, Christina Lacchetti et al. Journal of Clinical Oncology profile →
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

2020 367 citations Jennie R. Crews, Nancy E. Davidson et al. profile →
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update

2022 116 citations Sharon H. Giordano, Sarah Temin et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Nancy E. Davidson

Since Specialization

Citations

This map shows the geographic impact of Nancy E. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Davidson more than expected).

Fields of papers citing papers by Nancy E. Davidson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy E. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Davidson. The network helps show where Nancy E. Davidson may publish in the future.

Co-authorship network of co-authors of Nancy E. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy E. Davidson. A scholar is included among the top collaborators of Nancy E. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy E. Davidson. Nancy E. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gonadal Hormone Changes with Aging and Their Impact on Chronic Pain 2025 ·Cells ·(unknown), Nancy E. Davidson, (unknown), (unknown), Nebojša Nick Knežević	4
2	Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update 2019 ·Journal of Clinical Oncology ·Kala Visvanathan, Carol J. Fabian, Elissa Bantug, Abenaa M. Brewster, Nancy E. Davidson, Andrea DeCensi, Justin D. Floyd, Judy E. Garber, Erin Hofstatter, Seema A. Khan, Maria C. Katapodi, Sandhya Pruthi, (unknown), Carolyn D. Runowicz, Mark R. Somerfield	117
3	Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures 2018 ·Cancer Research ·Nilgun Tasdemir, (unknown), Zheqi Li, Li Zhu, Matthew J. Sikora, Kevin M. Levine, Britta M. Jacobsen, George C. Tseng, Nancy E. Davidson, Steffi Oesterreich	44
4	Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update breakdown → 2018 ·Journal of Clinical Oncology ·Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen A. Gelmon, Sharon H. Giordano, Clifford A. Hudis, (unknown), Vered Stearns, Eric P. Winer, Jennifer J. Griggs	411
5	Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure 2016 ·Clinical Cancer Research ·Bryan P. Schneider, Fei Shen, Laura Gardner, Milan Radovich, Lang Li, Kathy D. Miller, Guanglong Jiang, Dongbing Lai, Anne O’Neill, Joseph A. Sparano, Nancy E. Davidson, David Cameron, Irmina Gradus‐Pizlo, Ronald Mastouri, Thomas Suter, Tatiana Foroud, George W. Sledge	66
6	Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer 2016 ·Clinical Cancer Research ·Rekha Gyanchandani, Yan Lin, Hui‐Min Lin, Kristine Cooper, Daniel P. Normolle, Adam Brufsky, (unknown), (unknown), Steffi Oesterreich, Nancy E. Davidson, Rohit Bhargava, David J. Dabbs, Adrian V. Lee	53
7	Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition 2015 ·Cancer Prevention Research ·Tiffany A. Katz, Serena G. Liao, (unknown), Robert K. Dearth, Thushangi N. Pathiraja, Zhiguang Huo, Patricia Shaw, (unknown), Nancy E. Davidson, David G. Peters, George C. Tseng, Steffi Oesterreich, Adrian V. Lee	18
8	Invasive Lobular Carcinoma Cell Lines Are Characterized by Unique Estrogen-Mediated Gene Expression Patterns and Altered Tamoxifen Response 2014 ·Cancer Research ·Matthew J. Sikora, Kristine Cooper, Amir Bahreini, Soumya Luthra, Guoying Wang, Uma Chandran, Nancy E. Davidson, David J. Dabbs, Alana L. Welm, Steffi Oesterreich	87
9	Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 breakdown → 2014 ·Journal of Clinical Oncology ·Sylvia Adams, Robert J. Gray, Sandra Demaria, Lori J. Goldstein, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Molin Wang, Vicky Jones, Thomas J. Saphner, Antonio C. Wolff, William C. Wood, Nancy E. Davidson, George W. Sledge, Joseph A. Sparano, Sunil Badve	953
10	Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline 2014 ·Journal of Clinical Oncology ·Sharon H. Giordano, Sarah Temin, Jeffrey J. Kirshner, Sarat Chandarlapaty, Jennie R. Crews, Nancy E. Davidson, Francisco J. Esteva, Ana M. González-Angulo, Ian E. Krop, (unknown), Nancy U. Lin, Shanu Modi, Debra A. Patt, Edith A. Perez, Jane Perlmutter, Naren Ramakrishna, Eric P. Winer	258
11	Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial 2013 ·Clinical Cancer Research ·Bryan P. Schneider, Robert J. Gray, Milan Radovich, Fei Shen, Gail H. Vance, Lang Li, Guanglong Jiang, Kathy D. Miller, Julie R. Gralow, Maura N. Dickler, Melody Cobleigh, Edith A. Perez, (unknown), Kirsten Vang Nielsen, Sven Müller, Ann D. Thor, George W. Sledge, Joseph A. Sparano, Nancy E. Davidson, Sunil Badve	47
12	Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer 2013 ·Clinical Cancer Research ·Vered Stearns, Lisa K. Jacobs, (unknown), Theodore N. Tsangaris, Michelle A. Rudek, Michaela J. Higgins, Julie R. Lange, (unknown), Shannon A. Slater, Stacie C. Jeter, Penny Powers, Susanne Briest, Calvin Chao, Carl Yoshizawa, Elizabeth A. Sugar, Igor Espinoza‐Delgado, Saraswati Sukumar, Edward Gabrielson, Nancy E. Davidson	24
13	Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831 2013 ·Clinical Cancer Research ·Amylou C. Dueck, Monica M. Reinholz, Xochiquetzal J. Geiger, Kathleen Tenner, Karla V. Ballman, Robert B. Jenkins, Darren Riehle, Beiyun Chen, Ann E. McCullough, Nancy E. Davidson, Silvana Martino, George W. Sledge, Peter A. Kaufman, Leila A. Kutteh, Julie R. Gralow, Lyndsay N. Harris, James N. Ingle, Wilma L. Lingle, Edith A. Perez	19
14	Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831 2009 ·Journal of Clinical Oncology ·Michele Y. Halyard, Thomas M. Pisansky, Amylou C. Dueck, Vera J. Suman, Lori J. Pierce, (unknown), L.B. Marks, Nancy E. Davidson, Silvana Martino, Peter A. Kaufman, Leila A. Kutteh, Shaker R. Dakhil, Edith A. Perez	127
15	Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer 2009 ·Clinical Cancer Research ·Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, (unknown), Edith Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Robert P. Gray	21
16	Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100 2008 ·Journal of Clinical Oncology ·Bryan P. Schneider, Μolin Wang, Milan Radovich, George W. Sledge, Sunil Badve, Ann D. Thor, David A. Flockhart, Bradley A. Hancock, Nancy E. Davidson, Julie R. Gralow, Maura N. Dickler, Edith A. Perez, Melody Cobleigh, Tamara Shenkier, Susan M. Edgerton, Kathy D. Miller	487
17	Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases 2008 ·Clinical Cancer Research ·Julie M. Wu, Mary Jo Fackler, Marc K. Halushka, (unknown), (unknown), Wei Wen Teo, Constance A. Griffin, John H. Fetting, Nancy E. Davidson, Angelo M. De Marzo, Jessica Hicks, Dhananjay Chitale, Marc Ladanyi, Saraswati Sukumar, Pedram Argani	165
18	Comparative Analysis of Breast Cancer Contamination in Mobilized and Nonmobilized Hematopoietic Grafts 1996 ·Journal of Hematotherapy ·(unknown), (unknown), (unknown), José Luís Passos‐Coelho, John M. Davis, A M Huelskamp, Stephen J. Noga, Nancy E. Davidson, Esther M. John, Brenda Cooper, S L Gerson, H M Lazarus, Kent Holland, Stefan Glück, TJ Moss, (unknown), Linda T. Vahdat, Karen H. Antman	11
19	Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue. 1995 ·PubMed ·Diane E. McCloskey, Robert A. Casero, Patrick M. Woster, Nancy E. Davidson	72
20	Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. 1986 ·PubMed ·Thomas W. Kensler, Patricia A. Egner, Nancy E. Davidson, Bill D. Roebuck, (unknown), John D. Groopman	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact